Ken Griffin Wave Life Sciences Ltd. Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$4.38 - $6.48 $36,792 - $54,432	8,400 Added 115.07%	15,700 $78,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $9,912 - $19,152	2,800 Added 62.22%	7,300 $45,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $18,720 - $30,915	4,500 New	4,500 $22,000
Q2 2023 Aug 14, 2023	BUY	$3.51 - $4.69 $1,404 - $1,876	400 Added 3.25%	12,700 $46,000
Q1 2023 May 15, 2023	BUY	$3.58 - $6.3 $21,838 - $38,430	6,100 Added 98.39%	12,300 $53,000
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $19,716 - $43,400	6,200 New	6,200 $43,000

146

93.1M

33K

57.2K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $454M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.